PLERIXAFOR

Product NDC
70771-1776
11-digit product format
707711776
Labeler code
70771
Product ID
70771-1776_41b76e97-b780-4fc8-b073-13bf155ad8a5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
plerixafor
Dosage form
INJECTION
Route
SUBCUTANEOUS
Labeler
Zydus Lifesciences Limited
Application
ANDA208980
Marketing category
ANDA
Marketing start
2023-07-28
Substance
PLERIXAFOR
Active strength
24 mg/1.2mL
Pharmacologic classes
Hematopoietic Stem Cell Mobilizer [EPC], Increased Hematopoietic Stem Cell Mobilization [PE]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A208980-001PLERIXAFORPLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-2631067a03dcf5…
2025-08-23 18:47 UTC2025-08A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-266a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-265bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-2679d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-261e350fbaab3a…
2024-05-31 18:47 UTC2024-05A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-268072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-266a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-261c564ffb4f44…
2023-12-20 04:57 UTC2023-12A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-26ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-26a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUSAP2023-07-269b2671bbb829…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A208980-001PLERIXAFOR24MG/1.2ML (20MG/ML)SOLUTION / SUBCUTANEOUS2023-07-26a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2024-05-31 18:47 UTC2024-05A208980-001AP18072bd15b7f6…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A208980-001AP16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A208980-001AP11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A208980-001AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A208980-001AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A208980-001AP19b2671bbb829…

Additional Listing Data#

Finished product
Yes
Brand name base
PLERIXAFOR
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
PLERIXAFOR24 mg/1.2mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
S915P5499NInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
828700Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
43df348a-d7f2-4f14-8131-c916679a98ebAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e9e3bcdc-866b-12bf-8547-f275901d8135Product name220240828

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70771-1776-1PLERIXAFOR1.2 mL in 1 VIAL, SINGLE-USEINJECTION1.21
70771-1776-1PLERIXAFOR1 in 1 CARTONINJECTION11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70771-1776PLERIXAFOR INJECTION [ZYDUS LIFESCIENCES LIMITED]1Current NDC, 2 package rows20230728_43df348a-d7f2-4f14-8131-c916679a98eb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PLERIXAFORPLERIXAFORZydus Pharmaceuticals USA Inc.a0a058f9-1618-4853-9b8a-e9768ee86b392024-12-06Warnings, Adverse reactionsExact identifier
application applno (ANDA): 208980
application number: ANDA208980
PLERIXAFORPLERIXAFORZydus Lifesciences Limited43df348a-d7f2-4f14-8131-c916679a98eb2023-07-28Exact identifier
application applno (ANDA): 208980
application number: ANDA208980
ndc (product): 70771-1776

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
828700plerixafor 24 MG in 1.2 ML InjectionPSN43df348a-d7f2-4f14-8131-c916679a98eb1
8287001.2 ML plerixafor 20 MG/ML InjectionSCD43df348a-d7f2-4f14-8131-c916679a98eb1
828700plerixafor 24 MG per 1.2 ML InjectionSY43df348a-d7f2-4f14-8131-c916679a98eb1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
70771-1776-1707711776011 VIAL, SINGLE-USE in 1 CARTON (70771-1776-1) / 1.2 mL in 1 VIAL, SINGLE-USE2023-07-28NoNoCurrent